Systemic corticosteroids
Methylprednisolone
Aerosol corticosteriods
Fluticason
B2 adrenergic Ags
SABA = albuterol LABA = Salmeterol
Muscarinic blockers
* tiotropium
Phosphodiesterase blocker
Theophylline
Leukotriene pathway blocker
Montelukast
IgE inhbitors
Omalizumab
Asthma airway resistance
Reversible!
Hallmark of asthma
Early rxn = mast cell + t lymp
Late rxn = Neutrophil/eosinophil release in late rxn,
Maintenance therapy Rx
goal
* Affect airway responsiveness/reactivity
Quick relief Meds
Goals
Relieve bronchospasm in attack
*affect airway resistance
Topical delivery of aerosolized Rx
T.I. Effect?
UPs T.I.
Methylxanthines target
Cholinergic
ICS
Topical activity of ICS UPed by
17a sub
Effect corticosteriods on Airway cells
*DOWN cytokines
No effect on mediater release
*UP B2 receptors
ICS
S.E
B2 Ags
Effects
* inhibit release of mast cell mediators (less microvascular leakage)
Rescue tx
SABA
LABA used
Maintenance
ONLY w/ ICS
LABAs alnoe w/ COPD
Most asthma controlled w/
ICS + b2 ag
Albuterol
Time
Salmeterol
Time
Long-acting
>12 hrs
B2 ags
S.E.
*uncommon w/ short-acting b2
Tremor/tac/hypokalemia